RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 158 filers reported holding RECURSION PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,247,883 | -45.9% | 163,122 | -47.2% | 0.00% | 0.0% |
| Q2 2023 | $2,305,705 | +12.0% | 308,662 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,058,776 | -31.6% | 308,662 | -21.0% | 0.00% | 0.0% |
| Q4 2022 | $3,011,565 | -91.3% | 390,605 | -87.9% | 0.00% | -94.1% |
| Q3 2022 | $34,445,000 | +17.5% | 3,237,344 | -10.1% | 0.02% | +30.8% |
| Q2 2022 | $29,312,000 | +21.1% | 3,600,960 | +6.5% | 0.01% | +44.4% |
| Q1 2022 | $24,206,000 | -50.9% | 3,380,718 | +17.6% | 0.01% | -47.1% |
| Q4 2021 | $49,263,000 | +30.6% | 2,875,819 | +75.4% | 0.02% | +13.3% |
| Q3 2021 | $37,721,000 | -20.5% | 1,639,341 | +26.1% | 0.02% | -21.1% |
| Q2 2021 | $47,447,000 | – | 1,299,922 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kinnevik AB (publ) | 10,405,668 | $79,603,360 | 100.00% |
| Data Collective IV GP, LLC | 5,941,120 | $45,449,568 | 43.00% |
| MIC Capital Management UK LLP | 8,451,758 | $64,655,952 | 14.74% |
| MV Management XI, L.L.C. | 788,762 | $6,034,029 | 10.04% |
| ArchPoint Investors | 1,047,386 | $8,012,503 | 3.06% |
| Connective Portfolio Management, LLC | 33,000 | $252,000 | 0.77% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,335,132 | $17,863,760 | 0.70% |
| Diametric Capital, LP | 136,331 | $1,042,932 | 0.44% |
| ARK Investment Management | 6,876,598 | $52,605,973 | 0.40% |
| ALLEN OPERATIONS LLC | 217,657 | $1,665,076 | 0.37% |